Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A HITTMAIR

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
British Journal of Haematology|May 1, 1997
Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional statusA Egle, A Villunger, I Marschitz, et al.
The Journal of Pathology|July 6, 2000
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissueA Hobisch, H Rogatsch, A Hittmair, et al.
British Journal of Obstetrics and Gynaecology|July 30, 1999
Fulminant recurrence of a Sertoli-Leydig cell tumour during pregnancyM Widschwendter, G Meduri, H Loosfelt, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1993
Relationship between quantity of silver stained nucleolar organizer region associated proteins (Ag-NORs) and growth rate suppression of breast cancer cell lines after interferon-gamma and 4-hydroxy-tamoxifen treatmentD Ofner, A Hittmair, C Marth, et al.
Gynakologische Rundschau|January 1, 1990
[Metallothionein expression in normal endometrium and cancers of the uterus, ovary and breast]K W Schmid, A Hittmair, M Tötsch, et al.
International Journal of Oncology|November 20, 2001
Combined study of prostatic carcinoma by classical cytogenetic analysis and comparative genomic hybridizationI Verdorfer, A Hobisch, Z Culig, et al.
Histology and Histopathology|July 1, 1997
Hyperactive androgen receptor in prostate cancer: what does it mean for new therapy concepts?Z Culig, A Hobisch, A Hittmair, et al.
European Urology|January 1, 1995
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factorZ Culig, A Hobisch, M V Cronauer, et al.
The Prostate|July 1, 1997
Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cellsZ Culig, A Hobisch, A Hittmair, et al.
Cancer Research|October 15, 1994
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factorZ Culig, A Hobisch, M V Cronauer, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
British Journal of Haematology|May 1, 1997
Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional statusA Egle, A Villunger, I Marschitz, et al.
The Journal of Pathology|July 6, 2000
Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissueA Hobisch, H Rogatsch, A Hittmair, et al.
British Journal of Obstetrics and Gynaecology|July 30, 1999
Fulminant recurrence of a Sertoli-Leydig cell tumour during pregnancyM Widschwendter, G Meduri, H Loosfelt, et al.
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1993
Relationship between quantity of silver stained nucleolar organizer region associated proteins (Ag-NORs) and growth rate suppression of breast cancer cell lines after interferon-gamma and 4-hydroxy-tamoxifen treatmentD Ofner, A Hittmair, C Marth, et al.
Gynakologische Rundschau|January 1, 1990
[Metallothionein expression in normal endometrium and cancers of the uterus, ovary and breast]K W Schmid, A Hittmair, M Tötsch, et al.
International Journal of Oncology|November 20, 2001
Combined study of prostatic carcinoma by classical cytogenetic analysis and comparative genomic hybridizationI Verdorfer, A Hobisch, Z Culig, et al.
Histology and Histopathology|July 1, 1997
Hyperactive androgen receptor in prostate cancer: what does it mean for new therapy concepts?Z Culig, A Hobisch, A Hittmair, et al.
European Urology|January 1, 1995
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factorZ Culig, A Hobisch, M V Cronauer, et al.
The Prostate|July 1, 1997
Synergistic activation of androgen receptor by androgen and luteinizing hormone-releasing hormone in prostatic carcinoma cellsZ Culig, A Hobisch, A Hittmair, et al.
Cancer Research|October 15, 1994
Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factorZ Culig, A Hobisch, M V Cronauer, et al.
Pageof 10